Variables

4291 variables.
Clear
Module Label Name Description Type
Targeted serum metabolomics (CHRIS baseline) x0pt132 PC ae C34:3 Phosphatidylcholine acyl-alkyl C34:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt133 PC ae C36:0 Phosphatidylcholine acyl-alkyl C36:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt134 PC ae C36:1 Phosphatidylcholine acyl-alkyl C36:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt135 PC ae C36:2 Phosphatidylcholine acyl-alkyl C36:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt136 PC ae C36:3 Phosphatidylcholine acyl-alkyl C36:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt137 PC ae C36:4 Phosphatidylcholine acyl-alkyl C36:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt138 PC ae C36:5 Phosphatidylcholine acyl-alkyl C36:5 Float
Targeted serum metabolomics (CHRIS baseline) x0pt139 PC ae C38:0 Phosphatidylcholine acyl-alkyl C38:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt140 PC ae C38:1 Phosphatidylcholine acyl-alkyl C38:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt141 PC ae C38:2 Phosphatidylcholine acyl-alkyl C38:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt142 PC ae C38:3 Phosphatidylcholine acyl-alkyl C38:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt143 PC ae C38:4 Phosphatidylcholine acyl-alkyl C38:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt144 PC ae C38:5 Phosphatidylcholine acyl-alkyl C38:5 Float
Targeted serum metabolomics (CHRIS baseline) x0pt145 PC ae C38:6 Phosphatidylcholine acyl-alkyl C38:6 Float
Targeted serum metabolomics (CHRIS baseline) x0pt146 PC ae C40:1 Phosphatidylcholine acyl-alkyl C40:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt147 PC ae C40:2 Phosphatidylcholine acyl-alkyl C40:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt148 PC ae C40:3 Phosphatidylcholine acyl-alkyl C40:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt149 PC ae C40:4 Phosphatidylcholine acyl-alkyl C40:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt150 PC ae C40:5 Phosphatidylcholine acyl-alkyl C40:5 Float
Targeted serum metabolomics (CHRIS baseline) x0pt151 PC ae C40:6 Phosphatidylcholine acyl-alkyl C40:6 Float
Targeted serum metabolomics (CHRIS baseline) x0pt152 PC ae C42:0 Phosphatidylcholine acyl-alkyl C42:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt153 PC ae C42:1 Phosphatidylcholine acyl-alkyl C42:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt154 PC ae C42:2 Phosphatidylcholine acyl-alkyl C42:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt155 PC ae C42:3 Phosphatidylcholine acyl-alkyl C42:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt156 PC ae C42:4 Phosphatidylcholine acyl-alkyl C42:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt157 PC ae C42:5 Phosphatidylcholine acyl-alkyl C42:5 Float
Targeted serum metabolomics (CHRIS baseline) x0pt158 PC ae C44:3 Phosphatidylcholine acyl-alkyl C44:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt159 PC ae C44:4 Phosphatidylcholine acyl-alkyl C44:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt160 PC ae C44:5 Phosphatidylcholine acyl-alkyl C44:5 Float
Targeted serum metabolomics (CHRIS baseline) x0pt161 PC ae C44:6 Phosphatidylcholine acyl-alkyl C44:6 Float
Targeted serum metabolomics (CHRIS baseline) x0pt086 PC aa C24:0 Phosphatidylcholine diacyl C24:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt087 PC aa C26:0 Phosphatidylcholine diacyl C26:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt088 PC aa C28:1 Phosphatidylcholine diacyl C28:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt089 PC aa C30:0 Phosphatidylcholine diacyl C30:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt090 PC aa C30:2 Phosphatidylcholine diacyl C30:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt091 PC aa C32:0 Phosphatidylcholine diacyl C32:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt092 PC aa C32:1 Phosphatidylcholine diacyl C32:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt093 PC aa C32:2 Phosphatidylcholine diacyl C32:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt094 PC aa C32:3 Phosphatidylcholine diacyl C32:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt095 PC aa C34:1 Phosphatidylcholine diacyl C34:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt096 PC aa C34:2 Phosphatidylcholine diacyl C34:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt097 PC aa C34:3 Phosphatidylcholine diacyl C34:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt098 PC aa C34:4 Phosphatidylcholine diacyl C34:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt099 PC aa C36:0 Phosphatidylcholine diacyl C36:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt100 PC aa C36:1 Phosphatidylcholine diacyl C36:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt101 PC aa C36:2 Phosphatidylcholine diacyl C36:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt102 PC aa C36:3 Phosphatidylcholine diacyl C36:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt103 PC aa C36:4 Phosphatidylcholine diacyl C36:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt104 PC aa C36:5 Phosphatidylcholine diacyl C36:5 Float
Targeted serum metabolomics (CHRIS baseline) x0pt105 PC aa C36:6 Phosphatidylcholine diacyl C36:6 Float
Targeted serum metabolomics (CHRIS baseline) x0pt106 PC aa C38:0 Phosphatidylcholine diacyl C38:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt107 PC aa C38:1 Phosphatidylcholine diacyl C38:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt108 PC aa C38:3 Phosphatidylcholine diacyl C38:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt109 PC aa C38:4 Phosphatidylcholine diacyl C38:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt110 PC aa C38:5 Phosphatidylcholine diacyl C38:5 Float
Targeted serum metabolomics (CHRIS baseline) x0pt111 PC aa C38:6 Phosphatidylcholine diacyl C38:6 Float
Targeted serum metabolomics (CHRIS baseline) x0pt112 PC aa C40:1 Phosphatidylcholine diacyl C40:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt113 PC aa C40:2 Phosphatidylcholine diacyl C40:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt114 PC aa C40:3 Phosphatidylcholine diacyl C40:3 Float
Targeted serum metabolomics (CHRIS baseline) x0pt115 PC aa C40:4 Phosphatidylcholine diacyl C40:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt116 PC aa C40:5 Phosphatidylcholine diacyl C40:5 Float
Targeted serum metabolomics (CHRIS baseline) x0pt117 PC aa C40:6 Phosphatidylcholine diacyl C40:6 Float
Targeted serum metabolomics (CHRIS baseline) x0pt118 PC aa C42:0 Phosphatidylcholine diacyl C42:0 Float
Targeted serum metabolomics (CHRIS baseline) x0pt119 PC aa C42:1 Phosphatidylcholine diacyl C42:1 Float
Targeted serum metabolomics (CHRIS baseline) x0pt120 PC aa C42:2 Phosphatidylcholine diacyl C42:2 Float
Targeted serum metabolomics (CHRIS baseline) x0pt121 PC aa C42:4 Phosphatidylcholine diacyl C42:4 Float
Targeted serum metabolomics (CHRIS baseline) x0pt122 PC aa C42:5 Phosphatidylcholine diacyl C42:5 Float
Targeted serum metabolomics (CHRIS baseline) x0pt123 PC aa C42:6 Phosphatidylcholine diacyl C42:6 Float
Blood measurements (CHRIS baseline) x0lp25a Phosphorus (P) Phosphorus (P) Float
Blood measurements (CHRIS baseline) x0lp25 Phosphorus (P) Phosphorus (P) Float
Smoking (CHRIS baseline) x0sm54 Pipe smoking lifetime pack-years Pipe smoking lifetime pack-years Float
Heart rate variability (CHRIS baseline) x0ec268 Poincare SD1 Poincare SD1: in Poincare plot, SD1 represents the standard deviation perpendicular to the line-of-identity Float
Heart rate variability (CHRIS baseline) x0ec270 Poincare SD2/SD1 Poincare SD2/SD1: ratio between SD2 and SD1 Float
Heart rate variability (CHRIS baseline) x0ec269 Poincare SD2 Poincare SD2: in Poincare plot, SD2 represents the standard deviation along the line-of-identity Float
Blood measurements (CHRIS baseline) x0lp21 Potassium (K) Potassium (K) Float
Heart rate variability (CHRIS baseline) x0ec248 HF power (n.u.) (Welch) Power of HF band in normalised units, HF [n.u.] = LF [ms2] / (total power [ms2] - VLF [ms2]) x 100%, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in n.u. Float
Heart rate variability (CHRIS baseline) x0ec265 HF power (n.u.) (AR) Power of HF band in normalised units, HF [n.u.] = LF [ms2] / (total power [ms2] - VLF [ms2]) x 100%, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in n.u. Float
Heart rate variability (CHRIS baseline) x0ec247 LF power (n.u.) (Welch) Power of LF band in normalised units, LF [n.u.] = LF [ms2] / (total power [ms2] - VLF [ms2]) x 100%, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in n.u Float
Heart rate variability (CHRIS baseline) x0ec264 LF power (n.u.) (AR) Power of LF band in normalised units, LF [n.u.] = LF [ms2] / (total power [ms2] - VLF [ms2]) x 100%, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in n.u Float
Heart rate variability, cardiologist curated (CHRIS baseline) x0ec16 Power-law relationship of Heart Rate Variability Power-law relationship of Heart Rate Variability Float
Pain pressure threshold (CHRIS baseline) x0am01 Pressure pain measurement Pressure pain measurement Float
Targeted serum metabolomics (CHRIS baseline) x0pt023 Pro Proline Float
Targeted serum metabolomics (CHRIS baseline) x0pt058 C3:1 Propenoylcarnitine Float
Targeted serum metabolomics (CHRIS baseline) x0pt056 C3 Propionylcarnitine Float
Blood measurements (CHRIS baseline) x0lp02a Prothrombin time (PT) Prothrombin time (PT) Float
Blood pressure (CHRIS baseline) x0bp13 Pulse, CNAP Pulse (mean over ECG 20 min) Float
Targeted serum metabolomics (CHRIS baseline) x0pt024 Putrescine Putrescine Float
ECG 10s (CHRIS baseline) x0ec154b QTc (Baz), percent of the target QTc, calculated with Bazett formula, expressed as percentange of the target value of 390ms Float
ECG 10s (CHRIS baseline) x0ec154a QTc (Frid), percent of the target QTc, calculated with Fridericia formula, expressed as percentange of the target value of 390ms Float
Restless Legs Syndrome (CHRIS baseline) x0rd08 RLS duration (years) RLS-D duration Float
Heart rate variability (CHRIS baseline) x0ec217 RMSSD RMSSD: Square root of the mean squared differences between successive RR intervals, expressed in milliseconds Float
Heart rate variability (CHRIS baseline) x0ec281 RPA Lmean RPA Lmean: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. Lmean is the average diagonal line length Float
Heart rate variability (CHRIS baseline) x0ec282 RPA Shannon Entropy RPA Shannon Entropy: it is the entropy of the probability distribution of the diagonal line lengths Float
Heart rate variability (CHRIS baseline) x0ec278 RPA determinism RPA determinism: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The determinism (DET) is defined as the percentage of recurrence points which form diagonal lines Float
Heart rate variability (CHRIS baseline) x0ec279 RPA divergence RPA divergence: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The divergence (DIV) is defined as the inverse of Lmax Float
Heart rate variability (CHRIS baseline) x0ec277 RPA recurrence rate RPA recurrence rate: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The recurrence rate (REC) is defined as the ratio of ones and zeros in this RP matrix Float
Heart rate variability (CHRIS baseline) x0ec249 LF-HF power (Welch) Ratio between LF and HF band powers, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method Float
Heart rate variability (CHRIS baseline) x0ec266 LF/HF power (AR) Ratio between LF and HF band powers, with PSD estimated using parametric autoregressive (AR) modeling method Float
Blood measurements (CHRIS baseline) x0lp40 Red Blood Cell Count (RBC) Red Blood Cell Count (RBC) Float
Blood measurements (CHRIS baseline) x0lp46 Red Blood Cell Distribution Width (RDW) Red Blood Cell Distribution Width (RDW) Float
4291 variables.